Pfizer R&D Chief: Third dose may be needed within 6-12 months after full vaccination

Eren Sengezer FXStreet

Pfizer's Research and Development Chief says they continue to believe it is likely that a third dose booster may be needed within six to 12 months after full COVID-19 vaccination, Reuters reported on Wednesday, citing prepared remarks.

Additional takeaways

"Anticipating emergency use authorization submission for COVID-19 vaccine booster as early as August."

"In ongoing discussions with regulatory agencies regarding potential third dose booster of current COVID-19 vaccine."

"Planning to start immunogenicity and safety study in August to evaluate updated version of COVID-19 vaccine designed to target the delta variant."

"Projecting potential US emergency use authorization submission for oral COVID-19 anti-viral in Q4."

"Expecting to have safety & immunogenicity data to support US emergency use authorization for use in children ages 5 to 11 years old by end of September."

Market reaction

These comments don't seem to be having a significant impact on market sentiment. As of writing, S&P Futures were flat on the day at 4,394.

Author

Eren Sengezer

FXStreet

As an economist at heart, Eren Sengezer specializes in the assessment of the short-term and long-term impacts of macroeconomic data, central bank policies and political developments on financial assets.

EUR/USD flirts with daily highs, retargets 1.1900

EUR/USD regains upside traction, returning to the 1.1880 zone and refocusing its attention to the key 1.1900 barrier. The pair’s slight gains comes against the backdrop of a humble decline in the US Dollar as investors continue to assess the latest US CPI readings and the potential Fed’s rate path.

GBP/USD remains well bid around 1.3650

GBP/USD maintains its upside momentum in place, hovering around daily highs near 1.3650 and setting aside part of the recent three-day drop. Cable’s improved sentiment comes on the back of the Greenback’s irresolute price action, while recent hawkish comments from the BoE’s Pill also collaborate with the uptick.

Gold clings to gains just above $5,000/oz

Gold is reclaiming part of the ground lost on Wednesday’s marked decline, as bargain-hunters keep piling up and lifting prices past the key $5,000 per troy ounce. The precious metal’s move higher is also underpinned by the slight pullback in the US Dollar and declining US Treasury yields across the curve.

Crypto Today: Bitcoin, Ethereum, XRP in choppy price action, weighed down by falling institutional interest

Bitcoin's upside remains largely constrained amid weak technicals and declining institutional interest. Ethereum trades sideways above $1,900 support with the upside capped below $2,000 amid ETF outflows.

Week ahead – Data blitz, Fed Minutes and RBNZ decision in the spotlight

US GDP and PCE inflation are main highlights, plus the Fed minutes. UK and Japan have busy calendars too with focus on CPI. Flash PMIs for February will also be doing the rounds. RBNZ meets, is unlikely to follow RBA’s hawkish path.

Ripple Price Forecast: XRP potential bottom could be in sight

Ripple edges up above the intraday low of $1.35 at the time of writing on Friday amid mixed price actions across the crypto market. The remittance token failed to hold support at $1.40 the previous day, reflecting risk-off sentiment amid a decline in retail and institutional sentiment.